Advertisement

Topics

JLL Patheon Holdings, LLC Company Profile

17:44 EST 10th December 2018 | BioPortfolio


News Articles [427 Associated News Articles listed on BioPortfolio]

Patheon Expands Offerings and Capacity at Milton Park, UK Facility

Patheon, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, is increasing solid dose capabilities at its European sites. The lat...

Sears Holdings Seeks Court Approval Of Stalking Horse Asset Purchase Agreement With Service. ...

HOFFMAN ESTATES, Ill., Nov. 3, 2018 /PRNewswire/ -- Sears Holdings Corporation ("Holdings" or the "Company") (OTC Pink: SHLDQ) today announced that it has sought court Read more...

PTV News: Oct 20, 2009

Top stories on October 20th, 2009: Roche products re-branded Genentech in US Lonza drops US$ 460m bid for Patheon Boehringer's Micardis gets CVD sales boost AstraZeneca staff to "self-identify" them...

PTV News: Aug 24, 2009

Top stories on August 24th, 2009: The $3 billion price tag for Proctor and Gamble’s prescription drug business How much is Patheon worth? Lonza bids 460 million Dollar. Combining cell therapy and ...

Parnell Pharmaceuticals Holdings Ltd.: Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management

SYDNEY, AUSTRALIA / ACCESSWIRE / July 31, 2018 / Parnell Pharmaceuticals Holdings Ltd. (OTC PINK: PARNF) ("Parnell" or the "Company"), a fully integrated pharmaceutical company focused on developin...

Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmace...

M&As this week: Cosmos Holdings, Akebia Therapeutics, Biogen

Cosmos Holdings has signed a share purchase agreement to acquire 100% interest in Cosmofarm Ltd (Cosmofarm) for an undisclosed sum. The...Read More... The post M&As this week: Cosmos Holdings, A...

TRT Holdings, Inc. Exploring Possible Sale Of Gold's Gym

DALLAS, July 20, 2018 /PRNewswire/ -- TRT Holdings, Inc., the majority shareholder of Gold's Gym since 2004, says it will put the iconic fitness brand Read more...

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Antibiotic use on German pig farms - A longitudinal analysis for 2011, 2013 and 2014.

To study antibiotic use in livestock in a temporal context with the development of antimicrobial resistance, long-term changes in antibiotic use must be mapped and their possible causes must be explor...

Destroyed by Slavery? Slavery and African American Family Formation Following Emancipation.

This study introduces a new sample that links people and families across 1860, 1880, and 1900 census data to explore the intergenerational impact of slavery on black families in the United States. Sla...

Six-Year Prospective Outcomes of Primary Breast Augmentation With Nano Surface Implants.

Motiva Implants (Establishment Labs Holdings Inc.) are a novel family of silicone breast implants using cutting-edge technologies engineered to optimize aesthetic and safety outcomes.

Lovers, enemies, and friends: The complex and coded early history of lesbian comic strip characters.

This article seeks to recuperate four previously unexamined early newspaper comic strip characters that could lay the groundwork for queer comic studies. The titular characters in Lucy and Sophie Say...

Presence of two different bovine hepacivirus clusters in Germany.

During the last years, genetic information of hepaciviruses (family Flaviviridae), whose type species is the human hepatitis C virus, was detected in a wide range of primates and non-primate vertebrat...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

To afford urgent access to a potential-disease modifying treatment, Dr. Diana Kerwin, in partnership with CTD Holdings, the manufacturer of Trappsol (R) Cyclo(TM), will administer the prod...

Seqirus 2017 H7N9 With/Without MF59 (R) in Healthy Males and Non-pregnant Females, 18-64 Years of Age.

This is a randomized, double-blinded, Phase II study in healthy males and non-pregnant females, 18-64 years of age. This clinical trial is designed to assess the safety, reactogenicity, an...

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Frequent Fallers' Experiences of an Adapted Walking Frame, Designed to Reduce the Walking Aid's Associated Falls Risk

For some patients with mobility issues, a walking frame (commonly known as a zimmer frame - trademark of Zimmer Holdings), is provided to keep them on their feet and help them remain more ...

Companies [469 Associated Companies listed on BioPortfolio]

Patheon Inc.

Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosa...

JLL Patheon Holdings, LLC

Patheon N.V.

Patheon is a leading global provider of pharmaceutical development and manufacturing services. With approximately 9,100 employees and contractors worldwide, Patheon provides a com...

Patheon

Patheon, based in Toronto, Canada, is a leading international provider of pharmaceutical contract manufacturing and development services. Established in 1974, Patheon has grown into a fully integrated...

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

More Information about "JLL Patheon Holdings, LLC" on BioPortfolio

We have published hundreds of JLL Patheon Holdings, LLC news stories on BioPortfolio along with dozens of JLL Patheon Holdings, LLC Clinical Trials and PubMed Articles about JLL Patheon Holdings, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of JLL Patheon Holdings, LLC Companies in our database. You can also find out about relevant JLL Patheon Holdings, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record